1. Microarray-based Detection of Critical Overexpressed Genes in the Progression of Hepatic Fibrosis in Non-alcoholic Fatty Liver Disease: A Protein-protein Interaction Network Analysis
   Ali Mahmoudi et al, 2024, Current Medicinal Chemistry CrossRef
2. Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
   Leen J. M. Heyens et al, 2021, Frontiers in Medicine CrossRef
3. Astaxanthin attenuates hepatic steatosis in high-fat diet-fed rats by suppressing microRNA-21 via transactivation of nuclear factor erythroid 2-related factor 2
   Abdullah S. Shatoor et al, 2022, Journal of Physiology and Biochemistry CrossRef
4. The Critical Role of microRNA-21 in Non-alcoholic Fatty Liver Disease Pathogenesis
   Mingjing Liu et al, 2023, Current Pharmaceutical Design CrossRef
5. Micro RNAs as Emerging Therapeutic Targets in Liver Diseases
   Subheet Kumar Jain et al, 2022, Current Protein & Peptide Science CrossRef
6. Noncoding RNAs as additional mediators of epigenetic regulation in nonalcoholic fatty liver disease
   Mohamed Zaiou, 2022, World Journal of Gastroenterology CrossRef